勘误：血清微小RNA作为多发性硬化症生物标志物的综合评估。
Erratum: Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis.
出版信息
Neurol Neuroimmunol Neuroinflamm. 2016 Oct 7;3(6):e296. doi: 10.1212/NXI.0000000000000296. eCollection 2016 Dec.
Abstract
[This corrects the article on p. e267 in vol. 3, PMID: 27606352.].
摘要
[本文纠正了第3卷第e267页上的文章， PMID: 27606352。]
相似文献
1
Erratum: Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis.勘误：血清微小RNA作为多发性硬化症生物标志物的综合评估。
Neurol Neuroimmunol Neuroinflamm. 2016 Oct 7;3(6):e296. doi: 10.1212/NXI.0000000000000296. eCollection 2016 Dec.
2
Erratum: Glial cells express nuclear Nrf2 after fumarate treatment for multiple sclerosis and psoriasis.勘误：富马酸治疗多发性硬化症和银屑病后胶质细胞表达核 Nrf2。
Neurol Neuroimmunol Neuroinflamm. 2015 May 14;2(3):e116. doi: 10.1212/NXI.0000000000000116. eCollection 2015 Jun.
3
Erratum: NLR-Dependent Regulation of Inflammation in Multiple Sclerosis.勘误：多发性硬化症中炎症的 NLR 依赖性调节。
Front Immunol. 2018 Feb 28;9:404. doi: 10.3389/fimmu.2018.00404. eCollection 2018.
4
Erratum: Nasopharyngeal carcinoma in Brunei Darussalam: low incidence among the Chinese and an evaluation of antibodies to Epstein-Barr virus antigens as biomarkers.勘误：文莱达鲁萨兰国的鼻咽癌：华人中的低发病率以及对作为生物标志物的爱泼斯坦-巴尔病毒抗原抗体的评估。
Singapore Med J. 2014 Feb;55(2):107. doi: 10.11622/smedj.2014023.
5
Erratum: Characterization of sputum biomarkers for asthma-COPD overlap syndrome [Erratum].勘误：哮喘-慢性阻塞性肺疾病重叠综合征痰液生物标志物的特征[勘误]
Int J Chron Obstruct Pulmon Dis. 2017 Apr 18;12:1191. doi: 10.2147/COPD.S138685. eCollection 2017.
6
Erratum: Multiple sclerosis: Five new things.勘误：多发性硬化症：五件新事。
Neurol Clin Pract. 2014 Feb;4(1):4. doi: 10.1212/CPJ.0000000000000002.
7
Erratum: Relation between personality disorders and characteristics of multiple sclerosis patients and their parents.勘误：人格障碍与多发性硬化症患者及其父母的特征之间的关系。
J Educ Health Promot. 2018 Sep 14;7:122. doi: 10.4103/2277-9531.241137. eCollection 2018.
8
Erratum.勘误
Clin Mol Hepatol. 2015 Mar;21(1):104. doi: 10.3350/cmh.2015.21.1.104.
9
Erratum: Evaluating Treatment Decision for Multiple Sclerosis: Real Life and Patient Experiences.勘误：评估多发性硬化症的治疗决策：现实生活与患者体验。
Noro Psikiyatr Ars. 2019 Mar;56(1):82. doi: 10.29399/npa.23599.
10
Erratum to: High Seroprevalence and Index of Anti-John-Cunningham Virus Antibodies in Korean Patients with Multiple Sclerosis.《多发性硬化症韩国患者中抗约翰-坎宁安病毒抗体的高血清阳性率及指数》勘误
J Clin Neurol. 2020 Jan;16(1):180. doi: 10.3988/jcn.2020.16.1.180.
本文引用的文献
1
Comprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosis.血清 microRNAs 作为多发性硬化症生物标志物的综合评估。
Neurol Neuroimmunol Neuroinflamm. 2016 Aug 23;3(5):e267. doi: 10.1212/NXI.0000000000000267. eCollection 2016 Oct.
Zotero 插件